Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Uzoamaka Adaobi Okoli · Sankore

University of Nigeria

Uzoamaka Adaobi Okoli

ORCID, self-asserted

ORCID 0000-0002-4097-3697

This profile carries an ORCID the researcher published on their own record — the strongest evidence available short of a human confirming it. 7 other profiles were folded into this one.

Publications

21

Citations

206

h-index

6

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

6

Works published 2022 onward have been swept for this country. Figures are complete within that window, to the extent the open indexes are.

Affiliations

Every institution this scholar has appeared with on a work, by how many.

University of Nigeria25 works
University of Ibadan1 works

Publications

21 works in the graph, newest first.

Deciphering double-negative prostate cancer: from aggressive subtype to novel therapeutic paradigms
2026Cell Communication and SignalingJournalOpen access2 citations10.1186/s12964-026-02795-2
The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy
2026Military Medical ResearchJournalOpen access2 citations10.1016/j.mmr.2026.100038
The efficacy of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A meta-analysis and reconstructed individual patient data analysis
2026Human Vaccines & ImmunotherapeuticsJournalOpen accessCorresponding0 citations10.1080/21645515.2026.2626084
Tracing the Evolution of Sex Hormones and Receptor‐Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease
2025Advanced ScienceJournalOpen access20 citations10.1002/advs.202407715

Interactions between radiotherapy resistance mechanisms and the tumor microenvironment

2025Critical Reviews in Oncology/HematologyJournal16 citations10.1016/j.critrevonc.2025.104705

Efficacy of vacuum erectile device in refractory erectile dysfunction: a systematic review and meta-analysis

2025International Journal of Impotence ResearchJournal5 citations10.1038/s41443-025-01102-w

Exploring the efficacy of PARP inhibitors in metastatic castration-resistant prostate cancer with homologous recombination repair alteration: a meta-analysis based on subgroups and reconstructed individual patient data

2025International Journal of SurgeryJournalOpen accessCorresponding3 citations10.1097/js9.0000000000003338

The efficacy of abiraterone in metastatic hormone-sensitive prostate cancer: a stratified meta-analysis based on subgroups of low or high disease volume and reconstructed individual patient data

2025Expert Review of Anticancer TherapyJournalCorresponding6 citations10.1080/14737140.2025.2522981

How to fix neglect of Africa in pre-clinical studies

2025Nature AfricaJournalFirst author0 citations10.1038/d44148-025-00282-3

Comment remédier à la négligence de l'Afrique dans les études précliniques

2025Nature AfricaJournalFirst author0 citations10.1038/d44148-025-00283-2

Mechanistic insight and in-vitro validation of ampicillin/scoparone-functionalized ZnO nanoparticles as antioxidant, and antimicrobial therapeutics against antimicrobial-resistant Escherichia coli

2025Bioorganic ChemistryJournal2 citations10.1016/j.bioorg.2025.108764

Assessing the efficacy of darolutamide in metastatic hormone-sensitive prostate cancer based on subgroup meta-analysis and reconstructed individual patient data

2025Discover OncologyJournalOpen access1 citations10.1007/s12672-025-03875-4

The ISGylation tapestry in cancer: weaving phenotypic plasticity through multidimensional regulatory looms

2025Cellular & Molecular Biology LettersJournalOpen access1 citations10.1186/s11658-025-00815-6

The impact of exercise on prostate-specific antigen and testosterone in prostate cancer: a systematic review and meta-analysis

2025The Aging MaleJournalOpen accessCorresponding1 citations10.1080/13685538.2025.2549292

The efficacy and safety of enzalutamide in metastatic hormone-sensitive prostate cancer: a meta-analysis based on subgroups and reconstructed individual patient data

2025International Urology and NephrologyJournalCorresponding0 citations10.1007/s11255-025-04663-3

Interactions between oxidative stress and senescence in cancer: Mechanisms, therapeutic implications, and future perspectives

2024Redox BiologyJournalOpen access71 citations10.1016/j.redox.2024.103208

The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways

2024Cell Communication and SignalingJournalOpen access31 citations10.1186/s12964-024-01776-7

Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review

2024Pharmacological ResearchJournalOpen access23 citations10.1016/j.phrs.2024.107302

Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives

2024Chinese Journal of Cancer ResearchJournalOpen access21 citations10.21147/j.issn.1000-9604.2024.06.03

Personalized Food Avoidance Dietary Approach for Psoriasis and Hypertension: A Case Study and Pilot Trial

2024Nigerian Journal of Clinical PracticeJournalOpen access1 citations10.4103/njcp.njcp_152_24

The Role of Racial Disparities in Gene Expression Profiling for the Prediction of Therapeutic Response in Patients With Breast Cancer

2024JCO Global OncologyJournalOpen accessSenior author0 citations10.1200/go-24-14200